Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 9 Ovarian Neoplasms 8 Breast Neoplasms 7 Triple Negative Breast Neoplasms 3 Pancreatic Neoplasms 3 Neoplasms 2 Neoplasm Metastasis 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Fallopian Tube Neoplasms 2 Endometrial Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Advanced Solid Tumor 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thrombocytosis 1 Solid Tumors 1 Prostatic Neoplasms, Castration-Resistant 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Ovarian Neoplasm Epithelial 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Ovarian Neoplasm Epithelial × olaparib × Clear all

NCT04780945 2026-02-17

FAB

Leiden University Medical Center

Phase 2 Terminated

Ovarian Neoplasm Epithelial

Data powered by HemOnc (CC BY 4.0) Colophon ⚡